$16.28
-0.40-2.40%
At close: -
$16.28
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Centessa Pharmaceuticals (NASDAQ:CNTA) Stock, Earnings Estimates, EPS, And Revenue
Centessa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS Estimate
$-0.350
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$6.85M
Analyze the earnings history of Centessa Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Centessa Pharmaceuticals (CNTA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-12 | $-0.37 | $-0.42 | 11.9 % |
| Q2 | 2024-08-13 | $-0.40 | $-0.39 | -2.56 % |
| Q1 | 2024-05-13 | $-0.38 | $-0.43 | 11.6 % |
| Q4 | 2024-03-28 | $-0.38 | $-0.48 | 20.8 % |
Centessa Pharmaceuticals (CNTA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Centessa Pharmaceuticals (NASDAQ:CNTA) reporting earnings?
Centessa Pharmaceuticals (CNTA) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
What were the latest earnings per share (EPS) for Centessa Pharmaceuticals (NASDAQ:CNTA)?
The Actual EPS was $-0.37, which beat the estimate of $-0.42.
What were Centessa Pharmaceuticals’s (NASDAQ:CNTA) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.